MEGOLA, INC / ACORDY SA (OTCBB: MGON) PROVIDES SHAREHOLDER UPDATE WITH EXPANSION OF CANNABIS PRODUCTS TO US MARKETS
October 25 2018 - 9:30AM
Houston, Texas, Oct. 25, 2018 (GLOBE NEWSWIRE)
-- Publicly-held Megola, Inc. (OTC Pink: MGON) is pleased to
announce expansion of its products and sales distributions into the
United States and Canadian cannabis markets. Acordy President
Francisco Baez states: “Megola plans on introducing medical
marijuana products into the U.S. developed by it’s affiliated
company Acordy S.A. based in Malaga, Spain. Megola is also in
advanced negotiations with a U.S. developer of new, innovative and
therapeutic medical marijuana products”. Eric Ottens, CEO of Megola
states, “We are leveraging the already existing product set of
Acordy to quickly launch, produce and sell into the US and
Canadian cannabis markets.”
Francisco Baez also stated, “We have secured
legal counsel and we are taking the necessary steps to bring all
OTC filings current. While we are currently trading on the
Pinksheets, we plan on moving up to OTCQB or OTCQX within the next
6-12 months..”
The company also wishes to notify all
shareholders and persons of interest that Megola, Inc. will be
making announcements and updates via social media media. Updates
can be found at on newly created new social media channels on
Twitter https://twitter.com/MegolaMMJ and a Facebook Business Page
https://www.facebook.com/Megola-Inc-1844493719004617 .
Management also wants to notify all shareholders
and persons of interest to visit http://www.acordyinvest.com for
updates and notifications of the company’s original programs and
directives.
About Acordy SA.
Acordy S.A. is currently a privately owned
Spanish company that was formed in 2014. Acordy has been primarily
involved in the production and distribution of food items from
Spain with a concentration in olive oils and wines from the Iberian
Peninsula. Acordy is also involved with commercial horse breeding.
The company is currently planning to become involved in the
production and distribution of medical marijuana products and
already has the necessary infrastructure in place to commence
commercializing CBD products in the next three months.
###
Sections of this press release contain forward
looking statements that reflect management’s best judgement based
on factors currently known but involve significant risks and
uncertainties. Actual results could differ materially from those
anticipated in these forward looking statements as a result of a
number of factors that will be included in the forthcoming
financial statements. Forward looking information provided pursuant
to the safe harbor established by recent securities legislation
should be evaluated in the context of these
factors.
SOURCE Megola, Inc.
RELATED LINKS
http://www.acordyinvest.com
https://www.facebook.com/Megola-Inc-1844493719004617
https://twitter.com/MegolaMMJ
For further information, contact:
Eric Ottens
weottens@gmail.com
Megola (PK) (USOTC:MGON)
Historical Stock Chart
From Oct 2024 to Nov 2024
Megola (PK) (USOTC:MGON)
Historical Stock Chart
From Nov 2023 to Nov 2024